BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32839026)

  • 1. State of the science: Uterine sarcomas: From pathology to practice.
    Shushkevich A; Thaker PH; Littell RD; Shah NA; Chiang S; Thornton K; Hensley ML; Slomovitz BM; Holcomb KM; Leitao MM; Toboni MD; Powell MA; Levine DA; Dowdy SC; Klopp A; Brown J
    Gynecol Oncol; 2020 Oct; 159(1):3-7. PubMed ID: 32839026
    [No Abstract]   [Full Text] [Related]  

  • 2. Uterine sarcomas 2013.
    Sutton G
    Gynecol Oncol; 2013 Jul; 130(1):3-5. PubMed ID: 23769183
    [No Abstract]   [Full Text] [Related]  

  • 3. Current Status of Magnetic Resonance Imaging in Patients with Malignant Uterine Neoplasms: A Review.
    Huang YT; Huang YL; Ng KK; Lin G
    Korean J Radiol; 2019 Jan; 20(1):18-33. PubMed ID: 30627019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of 105 cases with uterine sarcoma.
    Yoney A; Eren B; Eskici S; Salman A; Unsal M
    Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine Adenosarcoma.
    Ulrich UA; Denschlag D
    Oncol Res Treat; 2018; 41(11):693-696. PubMed ID: 30326467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and pathologic study of 34 sarcomas of the uterus.
    Kenda R; De Palo G; Andreola S; Bandieramonte G; Lupi G; Musumeci R
    Tumori; 1981 Aug; 67(4):341-8. PubMed ID: 7314262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the treatment of sarcomas in gynecology.
    Lange SS; Novetsky AP; Powell MA
    Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical analysis of 153 uterine sarcomas].
    Bai P; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
    Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
    Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
    Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
    Sorbe B; Johansson B
    Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine sarcoma. Clinico-pathological characteristics and outcome.
    Sait HK; Anfinan NM; El Sayed ME; Alkhayyat SS; Ghanem AT; Abayazid RM; Sait KH
    Saudi Med J; 2014 Oct; 35(10):1215-22. PubMed ID: 25316466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine sarcoma 2008.
    Lin JF; Slomovitz BM
    Curr Oncol Rep; 2008 Nov; 10(6):512-8. PubMed ID: 18928666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with uterine sarcoma: the SARCUT study.
    Zapardiel I; Gracia Segovia M; Macuks R; Mancari R; Achimas-Cadariu P; Corrado G; Bartusevicius A; Sukhin V; Muruzabal JC; Coronado Martín PJ; Gardella B; Piek JM; Concin N; Arab C; Papatheodorou D; Polterauer S; Iacoponi S; Nieto T; Lopez-Sanclemente MC; Trukhan H; Gil MM; Bakinovskaya I; Dalamanava A; Cucurull M; Rovski D; Baquedano L; Chiva L; Mardas M; Mavrichev SA; Klat J; Lopez de la Manzanara CA; Yildirim Y;
    Int J Gynecol Cancer; 2023 Jun; 33(6):897-904. PubMed ID: 37192761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic treatment in adult uterine sarcomas.
    Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
    Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas.
    Wolfson AH; Wolfson DJ; Sittler SY; Breton L; Markoe AM; Schwade JG; Houdek PV; Averette HE; Sevin BU; Penalver M
    Gynecol Oncol; 1994 Jan; 52(1):56-62. PubMed ID: 8307502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in uterine sarcoma.
    Gadducci A
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.